Evidence map›Paper›PMID 34100093›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2021

Evaluation of treatment-associated eye toxicity after irradiation in childhood and adolescence-results from the Registry of the Evaluation of Side Effects after Radiotherapy in Childhood and Adolescence (RiSK).

Fenja Albrecht, Heidi Wolters, Yvonne Ziert, Beate Timmermann, Rolf-Dieter Kortmann, Christiane Matuschek, Christian Rübe, Carmen Martini, Hans Christiansen, Hans Theodor Eich and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Fenja AlbrechtDepartment of Radiotherapy, Medical School Hannover, Hannover, Germany. fenja.albrecht@stud.mh-hannover.de.
Heidi WoltersDepartment of Radiotherapy, University Hospital of Münster, Münster, Germany.
Yvonne ZiertInstitute of biometrics, Medical School Hannover, Hannover, Germany.
Beate TimmermannCenter for Proton Radiation Therapy, Paul-Scherrer-Institute, Villigen, Switzerland.
Rolf-Dieter KortmannDepartment of Radiotherapy, University of Leipzig, Leipzig, Germany.
Christiane MatuschekDepartment of Radiation Oncology, Heinrich Heine University Hospital of Düsseldorf, Düsseldorf, Germany.
Christian RübeDepartment of Radiotherapy and Radiation Oncology, Saarland University, Homburg/Saar, Germany.
Carmen MartiniDepartment of Radiotherapy, University Hospital of Freiburg, Freiburg, Germany.
Hans ChristiansenDepartment of Radiotherapy, Medical School Hannover, Hannover, Germany.
Hans Theodor EichDepartment of Radiotherapy, University Hospital of Münster, Münster, Germany.
Normann WillichDepartment of Radiotherapy, University Hospital of Münster, Münster, Germany.
Diana SteinmannDepartment of Radiotherapy, Medical School Hannover, Hannover, Germany.
Medizinische Hochschule Hannover · DEUniversity Hospital Münster · DEDüsseldorf University Hospital · DELeipzig University · DEPaul Scherrer Institute · CHSaarland University · DEUniversity Medical Center Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of the study is to evaluate treatment-related acute and late eye toxicity associated with radiation therapy in childhood and adolescence as correlated with RT (radiotherapy) doses.

methodsFrom 2001 to 2016, a total of 1725 children and adolescents undergoing radiation therapy were prospectively documented in the Registry of the Evaluation of Side Effects after Radiotherapy in Childhood and Adolescence (RiSK). The RTOG/EORTC criteria were used to classify ocular acute and late effects. Uni- and multivariate analyses were carried out to evaluate the impact of patient age, pre-existing impairments, and radiation dose on ocular toxicity.

resultsOf all documented patients, 593 received dose to the eye and formed the basis of this analysis. In 435 patients, information on acute reaction was available and graded 1, 2, 3, and 4 in 49, 17, 0, and 2 patients, respectively. Information on late toxicity was available in 268 patients and graded 1, 2, 3, and 4 in 15, 11, 11, and 5 patients, respectively. The acute toxicity rate was significantly higher in children who received a maximum dose > 50 Gy to the eye (p < 0.001) and who had a pre-existing eye impairment (p < 0.001 in multivariate analysis). The development of late toxicity was significantly higher for patients experiencing acute toxicity and having received a radiation dose > 50 Gy.

conclusionAcute and late toxicity both correlate with high radiation dose to the eye (> 50 Gy) and acute toxicity additionally with pre-existing eye impairments.

Indexed as

AdolescentAdultChildChild, PreschoolEyeEye InjuriesFemaleHumansInfantMaleRadiation InjuriesRadiotherapyRadiotherapy DosageRegistriesYoung AdultChildhoodEyeLate toxicityRadiationSide effects

Identifiers

PMID34100093
PMCPMC8292243
OpenAlexW3166559730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.